Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cryofocus Biotech Logo
Cryofocus Biotech Growth Score
89
CB Rank
107982
Heat Score
56
Cryofocus Biotech cryoablation device manufacturer.
Founded
obfuscation
PublicPost-IPO Equity Shanghai, Shanghai, China251-500 www.cryofocus.com/
Health Care
Overview

Cryofocus Biotech
Total Funding
obfuscation
Growth Score
89
Heat Score
56

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score89
-4 pts
in past quarter
Heat Score 56
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Cryofocus Biotech

CB Rank
107982
Cryofocus Biotech cryoablation device manufacturer.
Founded
obfuscation
PublicPost-IPO Equity Shanghai, Shanghai, China251-500 www.cryofocus.com/
Health Care

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Kangfeng Biotechnology (Shanghai) Co., Ltd.
Also Known As 康沣生物
Operating Status Active
Stock Symbol  HKG:06922
Company Type For Profit
About the Company
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.
Phone Number +86 21 209 77850
Contact Email info@cryofocus.com
Predictions & Insights

Products & Services

Cryoablation System for Atrial Fibrillation
A cryoablation system designed for the treatment of atrial fibrillation.
Cryoablation System for Hypertension
A cryoablation system aimed at treating resistant hypertension.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cryofocus Biotech Logo
Post-IPO Equity - Cryofocus Biotech
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 251-500
News
Technology
View Tech Report

Active Website Tech Count

16Cryofocus Biotech is actively using 16 technologies for its website, according to BuiltWith. These include HSTS, Euro, and  Mobile Non Scaleable Content.
Sub-Organizations
Frequently Asked Questions

Where is Cryofocus Biotech's headquarters? Cryofocus Biotech is located in Shanghai, Shanghai, China.Who invested in Cryofocus Biotech? Cryofocus Biotech has 11 investors including FutureX Capital and  Prox Ventures.When was the last funding round for Cryofocus Biotech? Cryofocus Biotech closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Cryofocus Biotech's competitors? Alternatives and possible competitors to Cryofocus Biotech may include PulseCare, Everpace, and  APT Medical.How much funding has Cryofocus Biotech raised to date? Cryofocus Biotech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|